AN2 Therapeutics, Inc.
ANTX
$1.28
$0.075.79%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/4/2025
-
TipRanks Financial Blog
3/25/2025
-
GuruFocus
3/25/2025
-
The Fly
3/25/2025
-
Business Wire
3/3/2025
-
GuruFocus
3/3/2025
-
Business Wire
2/26/2025
-
TipRanks Financial Blog
2/24/2025
-
The Fly
2/24/2025
-
Business Wire
2/20/2025
-
GuruFocus
2/20/2025
-
Business Wire
2/4/2025
-
Simply Wall St
2/3/2025
-
TipRanks Financial Blog
1/29/2025
-
GuruFocus
1/29/2025
-
Business Wire
1/28/2025
-
TipRanks Financial Blog
11/25/2024
-
TipRanks Financial Blog
11/21/2024
-
Simply Wall St
11/19/2024
-
TipRanks Financial Blog
11/18/2024
-
The Fly
11/18/2024
-
TipRanks Financial Blog
11/14/2024
-
Business Wire
11/13/2024
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 331 9090
Address
1800 El Camino Real
Menlo Park, CA 94027
Menlo Park, CA 94027
Country
Year Founded
Business Description
Sector
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, which is in...
more
